Pfizer has been granted patent in India by the Indian Patent Office for its vaccine Prevenar 13, used for protection against pneumonia. The grant of the patent means that Indian pharmaceutical firms will not be able to make the vaccine.
The development has, however, been decried by Medicines Sans Frontiers (MSF), an international medical humanitarian organization saying granting patent on the vaccine could impact its availability.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.50 |
| Dr. Reddys Lab | 1220.50 |
| Cipla | 1232.75 |
| Zydus Lifesciences | 927.80 |
| Lupin | 2321.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: